1933 Industries, Inc. (TGIF) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

6.53 k

Shareholding (Jan 2025)

FII

0.03%

Held by 1 FIIs

DII

99.97%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months

Poor long term growth as Operating profit has grown by an annual rate 11.06% of over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -3.45

Risky - Negative EBITDA

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Other Agricultural Products

Market cap

CAD 5 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.80

Return on Equity

69.61%

Price to Book

-1.19

Revenue and Profits:

Net Sales:

5 Million

(Quarterly Results - Apr 2025)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-50.0%

6 Months

-50.0%

1 Year

-50.0%

2 Years

-66.67%

3 Years

-80.0%

4 Years

-95.0%

5 Years

-95.0%

1933 Industries, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

3.21%

EBIT Growth (5y)

12.36%

EBIT to Interest (avg)

-3.11

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.80

Sales to Capital Employed (avg)

-0.18

Tax Ratio

100.00%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.03%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-1.19

EV to EBIT

-2.46

EV to EBITDA

-2.69

EV to Capital Employed

-8.19

EV to Sales

0.47

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

Bullish

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jan 2025

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.03%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is 6.82% vs 10.00% in Jan 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is 266.67% vs 50.00% in Jan 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Apr'25",
        "Jan'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.70",
          "val2": "4.40",
          "chgp": "6.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.80",
          "val2": "0.70",
          "chgp": "14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.60",
          "chgp": "-16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.50",
          "val2": "-0.30",
          "chgp": "266.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "156.30%",
          "val2": "108.10%",
          "chgp": "4.82%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jul'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jul 2024 is 14.79% vs 35.20% in Jul 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jul 2024 is 95.89% vs 19.34% in Jul 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jul'24",
        "Jul'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19.40",
          "val2": "16.90",
          "chgp": "14.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.00",
          "val2": "-7.90",
          "chgp": "49.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "1.70",
          "chgp": "-70.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.30",
          "val2": "-4.60",
          "chgp": "150.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.60",
          "val2": "-14.60",
          "chgp": "95.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-212.30%",
          "val2": "-560.70%",
          "chgp": "34.84%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ

Apr'25

Jan'25

Change(%)

Net Sales

4.70

4.40

6.82%

Operating Profit (PBDIT) excl Other Income

0.80

0.70

14.29%

Interest

0.50

0.60

-16.67%

Exceptional Items

0.20

0.00

Consolidate Net Profit

0.50

-0.30

266.67%

Operating Profit Margin (Excl OI)

156.30%

108.10%

4.82%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Apr 2025 is 6.82% vs 10.00% in Jan 2025

Consolidated Net Profit

QoQ Growth in quarter ended Apr 2025 is 266.67% vs 50.00% in Jan 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Jul'24

Jul'24

Jul'23

Change(%)

Net Sales

19.40

16.90

14.79%

Operating Profit (PBDIT) excl Other Income

-4.00

-7.90

49.37%

Interest

0.50

1.70

-70.59%

Exceptional Items

2.30

-4.60

150.00%

Consolidate Net Profit

-0.60

-14.60

95.89%

Operating Profit Margin (Excl OI)

-212.30%

-560.70%

34.84%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Jul 2024 is 14.79% vs 35.20% in Jul 2023

Consolidated Net Profit

YoY Growth in year ended Jul 2024 is 95.89% vs 19.34% in Jul 2023

All Annual Results

Company CV

About 1933 Industries, Inc.

1933 Industries, Inc.

Other Agricultural Products

1933 Industries Inc is a Canada-based vertically integrated cannabis company. The Company operates in the United States and Canada. Operating through subsidiaries, the Company owns licensed medical and adult-use cannabis cultivation and production assets, hemp-based, cannabidiol (CBD) infused products, CBD extraction services and a specialized cannabis advisory firm supporting clients in security, intelligence and due diligence. The Company holds interest in Alternative Medicine Association, LC (AMA), a licensed medical and adult-use cannabis cultivation and production facility, that produces its own line of cannabis-based products and manufactures other third-party brands. The Company’s subsidiary, Spire Global Strategy is a advisory company, that supports clients across the globe in government, finance, resources, heavy industry, and the emerging legal cannabis sector.

Company Coordinates

Company Details

Suite 300, 1055 West Hastings Street , VANCOUVER BC : V6E 2E9

Tel: 1 604 6744756

https://1933industries.com

Registrar Details